Uncategorized
VIDEO: Sustained-release ranibizumab ‘exceeds expectations’ for wet AMD
CHICAGO — Carl D. Regillo, MD, gives an update on the phase 2 LADDER study, a four-arm trial of sustained-release ranibizumab (Genentech), at the American Academy of Ophthalmology meeting here.